Immunis

Immunis

A private biotechnology company focused on the development of treatments for age-related and disease-related immune deficits.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
investor

€0.0

round
*

$25.0m

Series A
Total Funding000k
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads